Zeinab Kosibaty, PhD

Title(s)Postdoctoral Scholar, Medicine
SchoolSchool of Medicine
Address513 Parnassus Avenue, HSW
San Francisco CA 94143
Phone415-514-1083
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Tsukuba, JapanBSc2014Medical Sciences
    University of Tsukuba, JapanMSc2016Medical Sciences
    University of Tsukuba, JapanPhD2020Medical Sciences
    Karolinska Institutet, SwedenPostdoctoral Fellow2022Mechanism of drug resistance in lung adenocarcinoma

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Plasma RNA profiling unveils transcriptional signatures associated with resistance to osimertinib in EGFR T790M positive non-small cell lung cancer patients. Transl Lung Cancer Res. 2022 Oct; 11(10):2064-2078. Alexeyenko A, Brustugun OT, Eide IJZ, Gencheva R, Kosibaty Z, Lai Y, de Petris L, Tsakonas G, Grundberg O, Franzen B, Viktorsson K, Lewensohn R, Hydbring P, Ekman S. PMID: 36386450; PMCID: PMC9641044.
      View in: PubMed   Mentions:
    2. Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung Cancer. Cancers (Basel). 2022 Jul 14; 14(14). Kosibaty Z, Brustugun OT, Zwicky Eide IJ, Tsakonas G, Grundberg O, De Petris L, McGowan M, Hydbring P, Ekman S. PMID: 35884490; PMCID: PMC9317954.
      View in: PubMed   Mentions:
    3. High expression of Ras-specific guanine nucleotide-releasing factor 2 (RasGRF2) in lung adenocarcinoma is associated with tumor invasion and poor prognosis. Pathol Int. 2021 Apr; 71(4):255-260. Nakagawa T, Kim Y, Kano J, Murata Y, Kosibaty Z, Noguchi M, Sakamoto N. PMID: 33709437; PMCID: PMC8251786.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. ECT2 promotes lung adenocarcinoma progression through extracellular matrix dynamics and focal adhesion signaling. Cancer Sci. 2021 Feb; 112(2):703-714. Kosibaty Z, Murata Y, Minami Y, Noguchi M, Sakamoto N. PMID: 33215807; PMCID: PMC7893990.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    5. Cytoplasmic expression of epithelial cell transforming sequence 2 in lung adenocarcinoma and its implications for malignant progression. Lab Invest. 2019 04; 99(4):551-567. Kosibaty Z, Murata Y, Minami Y, Dai T, Kano J, Matsuoka R, Nakano N, Noguchi M. PMID: 30542068.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    Zeinab's Networks
    Concepts (26)
    Derived automatically from this person's publications.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _